$1.25 Billion is the total value of BRIDGER MANAGEMENT, LLC's 36 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 175.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
AMWL | New | AMERICAN WELL CORPcl a | $137,314,000 | – | 4,632,740 | +100.0% | 10.98% | – |
CZR | New | CAESARS ENTERTAINMENT INC NE | $75,931,000 | – | 1,354,466 | +100.0% | 6.07% | – |
ALC | Buy | ALCON AG | $56,840,000 | +16.9% | 998,066 | +17.6% | 4.54% | +0.9% |
HCA | New | HCA HEALTHCARE INC | $44,649,000 | – | 358,106 | +100.0% | 3.57% | – |
ALXN | New | ALEXION PHARMACEUTICALS INC | $43,306,000 | – | 378,454 | +100.0% | 3.46% | – |
MRK | New | MERCK & CO. INC | $38,675,000 | – | 466,246 | +100.0% | 3.09% | – |
ROST | New | ROSS STORES INC | $31,561,000 | – | 338,207 | +100.0% | 2.52% | – |
UBER | Buy | UBER TECHNOLOGIES INC | $29,184,000 | +44.5% | 800,000 | +23.1% | 2.33% | +24.7% |
IRWD | Buy | IRONWOOD PHARMACEUTICALS INC | $24,965,000 | +25.8% | 2,775,467 | +44.3% | 2.00% | +8.6% |
BMYRT | Buy | BRISTOL-MYERS SQUIBB COright 99/99/9999 | $9,961,000 | +52.4% | 4,427,269 | +142.5% | 0.80% | +31.6% |
ALEC | New | ALECTOR INC | $2,414,000 | – | 229,117 | +100.0% | 0.19% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-11-16
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
VERISIGN INC | 40 | Q1 2023 | 5.2% |
TEVA PHARMACEUTICAL INDS LTD | 40 | Q3 2023 | 7.3% |
MORGAN STANLEY | 35 | Q3 2023 | 11.8% |
ALNYLAM PHARMACEUTICALS INC | 34 | Q3 2021 | 4.9% |
POST HLDGS INC | 33 | Q4 2022 | 6.1% |
TG THERAPEUTICS INC | 33 | Q3 2021 | 3.8% |
CHARTER COMMUNICATIONS INC N | 30 | Q3 2023 | 7.2% |
ATARA BIOTHERAPEUTICS INC | 29 | Q4 2021 | 6.4% |
GODADDY INC | 28 | Q3 2023 | 8.9% |
CENTENE CORP DEL | 28 | Q3 2022 | 6.2% |
View BRIDGER MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Surrozen, Inc./DESold out | February 14, 2022 | 0 | 0.0% |
Atara Biotherapeutics, Inc. | February 16, 2021 | 1,524,760 | 1.8% |
Dicerna Pharmaceuticals Inc | February 14, 2020 | 1,981,633 | 2.9% |
TG THERAPEUTICS, INC. | February 14, 2020 | 1,907,492 | 1.9% |
CHIMERIX INCSold out | February 14, 2017 | 0 | 0.0% |
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.Sold out | February 14, 2017 | 0 | 0.0% |
SeaSpine Holdings CorpSold out | February 14, 2017 | 0 | 0.0% |
Trovagene, Inc.Sold out | February 14, 2017 | 0 | 0.0% |
ARROWHEAD RESEARCH CORPSold out | February 16, 2016 | 0 | 0.0% |
PENNYMAC FINANCIAL SERVICES, INC.Sold out | February 16, 2016 | 0 | 0.0% |
View BRIDGER MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-15 |
13F-HR/A | 2024-03-25 |
13F-HR/A | 2024-03-25 |
13F-HR/A | 2024-03-25 |
13F-HR/A | 2024-03-25 |
13F-HR/A | 2024-03-25 |
13F-HR/A | 2024-03-25 |
13F-HR/A | 2024-03-25 |
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
View BRIDGER MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.